Citadel Advisors’s Aravive, Inc. Common Stock ARAV Stock Holding History
Bought
Maintained
Sold
Other funds holding ARAV
GCP
AAA
TSS
Citadel Advisors's ARAV Position: Q3 2023 in Review
Citadel Advisors sold out of Aravive, Inc. Common Stock (ARAV) in Q3 2023, closing a stake of 107,555 shares — an estimated $67.6K sold.
Citadel Advisors first reported a position in ARAV in Q1 2014 and held it in 21 quarters. The position peaked at $3.94M in Q3 2015. 33 funds tracked by Wall St. Rank hold ARAV as of Q3 2023.
- Citadel Advisors reported no remaining Aravive, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Citadel Advisors sold 107,555 Aravive, Inc. Common Stock shares in Q3 2023, an estimated $67.6K.
- Citadel Advisors first reported a position in Aravive, Inc. Common Stock in Q1 2014 and held it in 21 quarters.
- Citadel Advisors's Aravive, Inc. Common Stock position peaked at $3.94M in Q3 2015.
- 33 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q3 2023.
Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.